Skip to main content
. 2012 Sep 6;14(12):1420–1428. doi: 10.1093/eurjhf/hfs135

Table 3.

Changes in left ventricular parameters with cardiac resynchronization therapy on by kidney function groupa

Baseline 12 months Paired difference P-value
P (between baseline and 12 months) P (between the paired differences)
LVEF (%)
 No CKD 27.1 (0.4) 32.0 (0.6) –5.0 (0.6) <0.001 0.048
 CKD 27.6 (0.7) 30.3 (0.9) –2.7 (0.9) 0.002
LVESV (mL)
 No CKD 197.7 (5.1) 159.8 (5.5) –37.8 (4.0) <0.001 0.019
 CKD 194.0 (6.9) 172.7 (7.6) –21.3 (5.1) <0.001
LVEDV (mL)
 No CKD 267.2 (6.0) 228.3 (6.3) –38.9 (4.4) <0.001 0.045
 CKD 265.8 (8.4) 242.9 (9.0) –22.9 (6.2) <0.001
LVESD (cm)
 No CKD 5.7 (0.1) 5.3 (0.1) –0.4 (0.1) <0.001 0.052
 CKD 5.6 (0.1) 5.5 (0.1) –0.1 (0.1) 0.46
LVEDD (cm)
 No CKD 6.8 (0.1) 6.5 (0.1) –0.3 (0.1) <0.001 0.10
 CKD 6.8 (0.1) 6.7 (0.1) –0.1 (0.1) 0.23
LV mass (g)
 No CKD 270.4 (6.7) 249.5 (6.2) –20.9 (4.6) <0.001 0.035
 CKD 274.3 (11.8) 273.3 (10.7) –1.0 (8.4) 0.91
Mitral regurgitation (%)
 No CKD 14.5 (0.9) 12.9 (0.9) –1.6 (0.9) 0.073 0.026
 CKD 15.4 (1.3) 17.4 (1.7) 2.0 (1.4) 0.16
LV cavity shape–diastole
 No CKD 0.53 (0.008) 0.48 (0.008) –0.057 (0.008) <0.001 0.0059
 CKD 0.52 (0.01) 0.50 (0.01) –0.016 (0.011) 0.14
IVMD (ms)
 No CKD 37.5 (3.1) 24.7 (2.7) –12.8 (3.2) <0.001 0.66
 CKD 24.1 (4.6) 14.0 (4.4) –10.1 (5.2) 0.057
MPI
 No CKD 971 (9.1) 961 (9.5) –10.6 (9.3) 0.26 0.23
 CKD 953 (16) 964 (18) 11 (16) 0.50

CKD, chronic kidney disease; IVMD, interventricular mechanical delay; LV cavity shape–diastole, left ventricular cavity shape at end-diastole; LVEDD, left ventricular end-diastolic diameter; LVEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; LVESD, left ventricular end-systolic diameter; LVESV, left ventricular end-systolic volume; LV mass, left ventricular mass; MPI, myocardial performance index.

aValues represent the mean (standard error).